Gender Differences: Does It Affect Clinical, Radiological and Microbiological Features in Adult Non-Cystic Fibrosis Bronchiectasis?

Objective: This study aimed to investigate the gender effect on the clin-ic, radiological, and microbiological features in adult non-cystic fibrosis bronchiectasis.Material and Methods: This was a cross-sectional study of 217 patients with adult non-CF BR. Patients with a confirmed diagnosis of bronchiectasis with high resolution computed tomography were investigated. Patients were clin-ically stable in the previous four weeks enrolled in the study. Symptoms, pul-monary function tests, radiological findings, microbiological results, and bronchiectasis severity index (BSI) were recorded. Results: The mean age of patients was 49.7±15.3 years (range 18-82). Fourty-one percent patients had smoking history. BR patients had a history of pneumonia sequel (47.9%), post-tuberculosis (33.6%) and idiopathic (15.7%). Patients divided into gender groups: females in group I, n=122 (56.2%)) and males in group II, n=95 (43.8%). There were differences in cough (84.4% vs 71.6%, p=0.029), smoking history (19.7% vs 75.9 %,p=0.001), chronic obstruc-tive pulmonary disease (4.1% vs 37. 9%, p=0.001), diabetes mellitus (21.3% vs 9.5%, p=0.025), depression history (36.1% vs 10.6%, p=0.001), panic disorders (10.7% vs 3.2%, p=0.039), long term oxygen usage (6.6% vs 17.9%,p=0.017). Forty-two percent of male BR patients had post-tuberculosis history, fifty-six female had post-pneumonia history, also. FEV1 and FVC value were high-er in man (1.5±0.7 vs 1.9±0.9,p= 0.001; 1.9±0.7 vs 2.7±1.0, p=0.0001 respec-tively). And also, FEV1/FVC ratio was lower in male (73.8±12.3 vs 67.8±15.3, p=0.01). There was no difference between gender and age, dyspnea, heam-optysis, BSI category, radiologic severity us ing Reiff’s score, microbiological features and bilevel positive airway pressure usage.Conclusion: We concluded that gender differences in non-CFBR might be clinically important in our study population. It is important to consider the gender differencesmight be effect symptoms, comorbidity, and pulmonary function test results in non-CF BR patients.

PDF

___

Pignataro FS, Bonini M, Forgione A, et al. Asthma and gen-der: The female lung. Pharmacological Research 2017; 119: 384-90.

Sakurai H, Samura H, Goya T, et al. Survival differences by gender for resected non-small cell lung cancer A ret-rospective analysis of 12 509 cases in a Japanese Lung Cancer Registry Study. J Thorac Oncol 2010; 5: 1594-601.

Rosenfeld M, Davis R, FitzSimmons S, et al. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997; 145: 794-803.

Mclntye K. Gender and survival in cystic fibrosis. Curr Opin Pulm Med 2013; 19: 692-97.

Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010; 65: Suppl. 1, i1-i58.

White AJ, Gompertz S, Bayley DL, et al. Resolution of bron-chial inflammation is related to bacterial eradication fol-lowing treatment of exacerbations of chronic bronchitis. Thorax 2003; 58(8): 680-85.

Reiff DB, Wells AU, Carr DH, et al. CT findings in bronchiec-tasis: limited value in distinguishing between idiopathic and specific types. AJR Am J Roentgenol 1995; 165: 261-67.

Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiec-tasis severity index. Am J Respir Crit Care Med 2014; 189(5): 576-85.

Weycker D, Hansen GL, Seifer FD. Prevalence and inci-dence of noncystic fibrosis bronchiectasis among US adults in 2013. Chronic Respir Dis 2017; 14: 377-84.

Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017; 50: 1700629.

Byun MK, Chang J, Kim HJ, et al. Differences of the lung mi-crobiome in patients with clinically stable and exacerbat-ed bronchiectasis. PLoS One 2017; 12(8): e0183553.

Leynaert B, Bousquet J, Hemry C, et al. Is bronchial hyper-responsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med 1997; 156: 1413-20.

Lanqdeau JB, Day A, Turcotte H, et al. Gender d’fferenc-es in the prevalence of airway hyperresponsiveness and asthma in athletes. Respir Med 2009; 103: 401-06.

Kavalcikova-Bogdanova N, Buday T, Plevkova J, et al. Chronic cough as a female gender issue. Advs Exp Med Biol. 2016; 905: 69-78.

Morice AH, Jakes AD, Faruqi S, et al. A worldwide survey of chronic cough: a manifestation of enhanced somatosen-sory response. Eur Respir J. 2014; 44: 1149-55.

Campainha S, Ribeiro C, Guimarae M, et al. Case report vocal cord dysfunction: a frequently forgotten entitiy. Case Rep Pulmonol. 2012; 2012: 525493.

HarmsCA. Does gender affect pulmonary function and exercise capacity? Respir Physiol Neurobiol. 2006; 151: 124 -31.

Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabe-tes in Turkish adults. Eur J Epidemiol 2013; 28: 169-80.

Wild S, Roglic G, Green A, et al. Global prevalence of diabe-tes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.

Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabe-tes in Turkish adults. Eur J Epidemiol 2013; 28: 169-80.

Steward JI, Maselli DJ, Anzueto A, et al. Clinical impact of CT radiological feature of bronchiectasis in the COPDGene cohort. Am J Respir Crit Care Med 2012; 185: A3656.

de Torres JP, Casanova C, Pinto-Plata V, et al. Gender differ-ences in plasma biomarker level in a cohort of COPD pa-tients: a pilot study. PLoS One 2011; 6(1): e16021.

Harms CA. Does gender affect pulmonary function and ex-ercise capacity? Respiratory Physiology and Neurobiology 2006; 151: 124-31.

Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Translational Research 2013; 162: 20 8 -18 .

Olveira C, Olveira G, Espildora F, et al. Mediterranean diet is associated with symptoms of depression and anxiety in patients with bronchiectasis. General Hospital Psychiatry 2014; 36: 277-83.

Özgün Niksarlıoğlu EY, Özkan G, Günlüoğlu G, et al. Factors related to depression and anxiety in adults with bronchi-ectasis. Neuropscy Dis Treat 2016; 12: 3005-10.

Angrill J, Agusti C, de Celis R, et al. Bacterial colonization in patients with bronchiectasis: microbiologic pattern and risk factors. Thorax 2002; 57: 15-9

Vidaillac C, Yong VFL, Jaggi TK, et al. Gender differences in bronchiectasis: a real issue? Breathe 2018; 14: 108-21.

Pinkerton KE, Harbaugh M, Han MK, et al. Women and lung disease. Sex differences and global health dispari-ties. Am J Respir Crit Care Med 2015; 192: 11-6.

Costa JC, Machado JN, Ferreira C, et al. The bronchiecta-sis severity index and FACED score for assessment of the severity of bronchiectasis. Pulmonology 2018; 24: 149-54.

Amorim A, Meira L, Redondo M, et al. Chronic bacterial infection prevalence, risk factors, and characteristics: A bronchiectasis population-based prospective study. J Clin Med. 2019; 8: 315.